priavoid.com
  • Home
  • About us
    • Overview
    • Strategy
    • Management
    • Supervisory Board
    • Scientific Advisory Board
    • History
  • Drug Development
    • Therapeutic Focus
    • Technology
    • Pipeline
  • Investors and Media
    • News
    • Events
    • Partnering
    • Archive
  • Contact us
    • Careers
Seite wählen

Prof. Willbold´s interview with PharmaVentures

November 14th, 2017

Learn more
Düsseldorf-Jülich Symposium on Neurodegenera7ve Diseases 2017 Bildquelle: Fotolia

Prof. Dieter Willbold talks with Summer Park of PharmaVentures at Biotech and Money Investival, London in 2017.

News & Events:

Nobel Prize winner Stanley Prusiner joins Priavoid’s supervisory board

Nobel Prize winner Stanley Prusiner joins Priavoid’s supervisory board

9. Dezember 2020
New CEO of Priavoid

New CEO of Priavoid

2. September 2020
Priavoid Headquarters at LSC Düsseldorf

Priavoid Headquarters at LSC Düsseldorf

6. März 2020
BIO-EUROPE SPRING 2020

BIO-EUROPE SPRING 2020

3. März 2020
Seed Investment

Seed Investment

6. Mai 2019
Prof. Willbold´s interview with PharmaVentures

Prof. Willbold´s interview with PharmaVentures

23. Januar 2018
Clinical trial with PRI-002

Clinical trial with PRI-002

31. Mai 2017
  • Home
  • Investors and Media
  • Legal Notice
  • Privacy Policy
  • Contact us
Copyright © 2019 Priavoid GmbH